Skip to content

The Importance of Blastocyst Diamater and Its Correlation to Reproductive Outcomes in PGT-A Cases

The Importance of Blastocyst Diamater and Its Correlation to Reproductive Outcomes in PGT-A Cases

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05499988
Enrollment
1000
Registered
2022-08-12
Start date
2022-08-07
Completion date
2023-12-31
Last updated
2022-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility

Keywords

Blastocyst diameter, PGT-A, Time lapse, Blastocyst survival, TE biopsy

Brief summary

Morphometric measurement of blastocyst diameter was taken on the day of trophoectoderm biopsy. PGT-A was done using NGS platform, followed by thawing and transfer of euploid blastocyts. Follow up of the Pregnancy and implantation rates is done and recorded to study the correlation between the diameter and reproductive outcomes of the blastocyst.

Detailed description

Blastocyst morphological grading proposed by Gardner and Schoolcraft including the expansion degree, inner cell mass, and trophoectoderm assessment has proved its importance. Blastocyst expansion degree that can presented in diameter is linked to the blastocyst implantation and overall success. In order to evaluate the importance of blastocyst diameter in PGT-A cases, measurements will be taken on the day of trophoectoderm biopsy TE (diameter in μm), followed by TE biopsy using flicking technique. Next, PGT-A will be done using NGS platform and results will be confirmed using PGT-ai. Thawing of euploid blastocyst will take place and expansion degree, survival rate will be recorded. Patient will be followed up for the clinical pregnancy and implantation rates.

Interventions

None listed

Sponsors

Ganin Fertility Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Female aged 18-45 years old * Male aged 18-60 years old * ICSI cases having PGT-A for their blastocysts * Must have their blastocysts cultured in time lapse incubator

Exclusion criteria

* Presence of any of the endometrial factors that affect embryo implantation such as hydrosalpings, adenomyosis or previous uterine infection * Any contradictions to undergoing in vitro fertilization or gonadotropin stimulation * Use of donor oocytes or sperm * Use of gestational carrier

Design outcomes

Primary

MeasureTime frameDescription
Blastocoele re-expansion degreeTwo hours post thawingDefined as the degree of blastocoele re-expansion and presented in %
Pregnancy rate15 days post embryo transferDefined as clinical pregnancy per transfer
Implantation rate6-8 weeks of pregnancyDefined as number of gestational sacs with fetal heart beat, shown by ultrasound in gestational week 6 over number of embryo transferred.
Blastocyst survival rateTwo hours post thawingDefined as the proportion of blastocysts that showed expansion degree ≥50% and their cells remained intact after thawing and re-expansion

Countries

Egypt

Contacts

Primary ContactEman Hasanen, BSc.
em.saber@gmail.com01282012291
Backup ContactManar Hozayen, MSc.
manarnrc@gmail.com01229483320

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026